| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |